170 Harbor Way
South San Francisco
About Neurona Therapeutics
Neurona Therapeutics is a pre-clinical stage biotechnology company focused on regenerative cell-based therapeutics to treat intractable neurological disease. Neurona's initial aim is to develop therapeutic compositions of specialized nerve cells for targeted delivery into the injured nervous system. The Company's founders comprise thought leaders in neuroscience and stem cell biology and are responsible for key advances in these fields. Neurona Therapeutics is located in South San Francisco, CA.
YEAR FOUNDED: 2013
Founders: Arnold Kriegstein, Cory R. Nicholas, John Rubenstein and Arturo Álvarez-Buylla
Founder and CEO: Cory R. Nicholas
Chairman of the Board: Tim Kutzkey
5 articles with Neurona Therapeutics
Neurona Therapeutics Raises $41.5M to Advance Neural Network-Rebalancing Cell Therapies for the Treatment of Epilepsy and other Neurological Disorders
Neurona Therapeutics Inc. today announced the successful completion of a $41.5 million financing.
Neurona Therapeutics Presents Clinical Development Plan for Lead Cell Therapy Program at the 16th Conference on Antiepileptic Drug and Device Trials (AEDD TRIALS XVI)
Neurona today announced the presentation of clinical trial plans and supporting preclinical data for its lead inhibitory neuron cell therapy candidate, NRTX-1001.
Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Program, Demonstrating Significant Seizure Suppression in Model of Focal EpilepsyData presented at American Academy of Neuroscience (AAN) Annual Meeting
Neurona Therapeutics , a biotherapeutics company advancing neural cell therapies for the treatment of neurological disorders, today announced the presentation of preclinical data from its lead inhibitory neuron cell therapy program, which is being developed for the treatment of drug-resistant focal epilepsy.
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.